Bruce Bodaken, Karin Eastham, and Jorge Garces have been appointed to the board of directors of molecular diagnostics firm AltheaDx.
Bodaken served as chairman and CEO of Blue Shield of California from January 2000 to December 2012, and he currently serves on the boards of directors of Rite Aid and WageWorks. He also is on the board of directors of the Institute of Medicine's Roundtable on Value and Science-Driven Healthcare, and is a visiting scholar at the Brookings Institution.
Eastham serves on the boards of directors of lllumina, Veracyte, MorphoSys, and Geron. She previously was executive VP, COO, and a member of the board of trustees of the Burnham Institute for Medical Research.
Garces has been president of AltheaDx since February 2014 and the firm's COO since June 2013. Prior to joining AltheaDx, he was senior VP of R&D at GenMark Diagnostics, CEO and president of Enigma Diagnostics, and VP and site operations manager of Hologic.
Myriad Genetics announced that R. Bryan Riggsbee will be its new executive VP, CFO, and treasurer starting October 16. In the interim, Jim Evans will continue to serve as CFO.
Prior to joining Myriad, Riggsbee was senior VP of corporate finance at Laboratory Corporation of America. Before that, he held various positions at General Electric and worked in the audit division at KPMG.